(PDF) P2.15-31 the Evolution of Costs in the Treatment of

P2.15-31 the Evolution of Costs in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Ontario, Canada Between 1999 to 2014

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1473

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

P1.15-28 Real World Treatment Patterns and Survival of Stage IV Non-Small Cell Lung Cancer (NSCLC) in Ontario, Canada

Journal of Thoracic Oncology

Respiratory Medicine

English

Pcn221 - Stage Iii Unresectable Non-Small Cell Lung Cancer Treatment Patterns and Costs: An Ontario, Canada Analysis

Value in Health

Occupational Health

English

Pcn120 - Epidemiology and Costs of Non-Small Cell Lung Cancer (Nsclc) in Austria

Value in Health

Occupational Health

English

P2.15-16 Clinical Economic Impact of Improved Genotyping in Patients With Advanced Non-Small Cell Lung Adenocarcinoma (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy

English

Gefitinib in Pretreated Advanced Non-Small Cell Lung Cancer (Nsclc): Analysis of Efficacy

Research in Oncology

English

Single‐Agent Paclitaxel in the Treatment of Advanced Non‐Small Cell Lung Cancer

Cancer Research

English

P3.04-17 Cost-Effectiveness of Atezolizumab for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in Canada

Journal of Thoracic Oncology

Respiratory Medicine

English

Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer

Cardiovascular Medicine

Intensive Care Medicine

Respiratory Medicine

English